Y020-8298 Screening compound: 3,4-dihydropyrimido[1,2-a][1,3]benzimidazol-1(2H)-yl(phenyl)methanone

Y020-8298 Screening compound: 3,4-dihydropyrimido[1,2-a][1,3]benzimidazol-1(2H)-yl(phenyl)methanone
Y020-8298 Screening compound: 3,4-dihydropyrimido[1,2-a][1,3]benzimidazol-1(2H)-yl(phenyl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-8298
3,4-dihydropyrimido[1,2-a][1,3]benzimidazol-1(2H)-yl(phenyl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-8298

Molecular Formula

C17H15N3O (C17 H15 N3 O)

Compound Name

3,4-dihydropyrimido[1,2-a][1,3]benzimidazol-1(2H)-yl(phenyl)methanone

IUPAC name

10-benzoyl-1810-triazatricyclo[7.4.0.0^{27}]trideca-2468-tetraene

SMILES

O=C(c1ccccc1)N1c2nc(cccc3)c3n2CCC1

InChI

InChI=1S/C17H15N3O/c21-16(13-7-2-1-3-8-13)20-12-6-11-19-15-10-5-4-9-14(15)18-17(19)20/h1-5,7-10H,6,11-12H2

InChI Key

QUUZBEZNWNMSLR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01136085

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

277.33

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.203

Distribution Coefficient, logD

3.203

Water Solubility, LogSw

-3.14

Polar Surface Area

25.479

Acid Dissociation Constant (pKa)

21.88

Base Dissociation Constant (pKb)

2.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.60

Y020-8298 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Anti-infective Library (19449 compounds)

DGK Inhibitors Library (10558 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Epigenetic
  • Epigenetic

References: we are preparing a list of scientific research reports with Y020-8298 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-8298?
Check Price and Availability of Y020-8298, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-8298 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-8298
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-8298
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-8298 available by request